IMVT - Immunovant Inc (Healthcare: Biotechnology) Projected Earnings Date: 2025-08-28    (Delayed quote data   2025-07-11)
Last
 18.13		 Change
 ⇑ +0.63   (+3.60%)		 Volume
  1,272,831
Open
 17.07		 High
 18.23		 Low
 17.07
8EMA (Daily)
 17.13		 40EMA (Daily)
 16.14		 50EMA (Daily)
 16.17		 STO (Daily)
 87.376		 MACD Hist (Daily)
 0.367
8EMA (Weekly)
 16.490		 40EMA (Weekly)
 20.13		 50EMA (Weekly)
 21.14		 STO (Weekly)
 63.047		 MACD Hist (Weekly)
 1.228
Company Profile
Immunovant Inc is a clinical-stage biopharmaceutical company. It is focused on enabling normal lives for patients with autoimmune diseases. The company's product includes IMVT-1401 targets the neonatal Fc receptor (FcRn).
optionchance optionchance
⇒ Home | Chart and Research | Education | About Us  

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Questions or Comments: support@optionchance.com
Copyright © 2025 OptionChance.com